These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 18043786)

  • 1. An audit of INR control in the Australian indigenous setting.
    Pickering A; Thomas DP
    Aust Fam Physician; 2007 Nov; 36(11):959-60, 967. PubMed ID: 18043786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-dose adjustment versus no adjustment of warfarin in stably anticoagulated patients with an occasional international normalized ratio (INR) out of range.
    Schulman S; Melinyshyn A; Ennis D; Rudd-Scott L
    Thromb Res; 2010 May; 125(5):393-7. PubMed ID: 19640572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of warfarin in paediatric patients with prosthetic cardiac valves: a retrospective audit.
    Wong CS; Batchelor K; Bua J; Newall F
    Thromb Res; 2011 Oct; 128(4):331-4. PubMed ID: 21620442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased warfarin doses and decreased international normalized ratio response after nationwide generic switching.
    Halkin H; Shapiro J; Kurnik D; Loebstein R; Shalev V; Kokia E
    Clin Pharmacol Ther; 2003 Sep; 74(3):215-21. PubMed ID: 12966365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreasing warfarin sensitivity during the first three months after heart valve surgery: implications for dosing.
    Meijer K; Kim YK; Schulman S
    Thromb Res; 2010 Mar; 125(3):224-9. PubMed ID: 19336266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.
    Clark NP; Witt DM; Delate T; Trapp M; Garcia D; Ageno W; Hylek EM; Crowther MA;
    Pharmacotherapy; 2008 Aug; 28(8):960-7. PubMed ID: 18657012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are brand-name and generic warfarin interchangeable? Multiple n-of-1 randomized, crossover trials.
    Pereira JA; Holbrook AM; Dolovich L; Goldsmith C; Thabane L; Douketis JD; Crowther MA; Bates SM; Ginsberg JS
    Ann Pharmacother; 2005; 39(7-8):1188-93. PubMed ID: 15914517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Warfarin therapeutic monitoring: is 70% time in the therapeutic range the best we can do?
    Lader E; Martin N; Cohen G; Meyer M; Reiter P; Dimova A; Parikh D
    J Clin Pharm Ther; 2012 Aug; 37(4):375-7. PubMed ID: 22171554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed discharges due to initiation of warfarin in atrial fibrillation: a prospective audit.
    Tan ES; Bonnett TJ; Abdelhafiz AH
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):232-5. PubMed ID: 17996662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interval between prothrombin time tests and the quality of oral anticoagulants treatment in patients with chronic atrial fibrillation.
    Shalev V; Rogowski O; Shimron O; Sheinberg B; Shapira I; Seligsohn U; Berliner S; Misgav M
    Thromb Res; 2007; 120(2):201-6. PubMed ID: 17118431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between chromogenic factor X and international normalized ratio differs during early warfarin initiation compared with chronic warfarin administration.
    Rosborough TK; Jacobsen JM; Shepherd MF
    Blood Coagul Fibrinolysis; 2009 Sep; 20(6):433-5. PubMed ID: 19543077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-management of anticoagulation.
    Levi M
    Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):979-85. PubMed ID: 18666848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of hospitalization on oral anticoagulation control: a population-based study.
    van Walraven C; Austin PC; Oake N; Wells P; Mamdani M; Forster AJ
    Thromb Res; 2007; 119(6):705-14. PubMed ID: 16844204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal initial dose adjustment of warfarin in orthopedic patients.
    Lenzini PA; Grice GR; Milligan PE; Gatchel SK; Deych E; Eby CS; Burnett RS; Clohisy JC; Barrack RL; Gage BF
    Ann Pharmacother; 2007 Nov; 41(11):1798-804. PubMed ID: 17911206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of patients on warfarin by general dental practitioners in South West Wales: continuing the audit cycle.
    Dewan K; Bishop K; Muthukrishnan A
    Br Dent J; 2009 Feb; 206(4):E8; discussion 214-5. PubMed ID: 19214196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrice weekly warfarin administration in haemodialysis patients.
    Sood MM; Rigatto C; Bueti J; Lang C; Miller L; PonnamPalam A; Reslerova M; Sood A; Komenda P
    Nephrol Dial Transplant; 2009 Oct; 24(10):3162-7. PubMed ID: 19487735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of anticoagulation care in patients discharged from a pharmacist-managed anticoagulation clinic after stabilization of warfarin therapy.
    Garwood CL; Dumo P; Baringhaus SN; Laban KM
    Pharmacotherapy; 2008 Jan; 28(1):20-6. PubMed ID: 18154470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy and clinical usefulness of the CoaguChek S and XS Point of Care devices when starting warfarin in a hospital outreach setting.
    Sobieraj-Teague M; Daniel D; Farrelly B; Coghlan D; Gallus A
    Thromb Res; 2009 Apr; 123(6):909-13. PubMed ID: 19042011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Warfarin induction at 5 mg daily is safe with a low risk of anticoagulant overdose: results of an audit of patients with deep vein thrombosis commencing warfarin.
    Harper P; Monahan K; Baker B
    Intern Med J; 2005 Dec; 35(12):717-20. PubMed ID: 16313547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of warfarin among patients with cancer.
    Rose AJ; Sharman JP; Ozonoff A; Henault LE; Hylek EM
    J Gen Intern Med; 2007 Jul; 22(7):997-1002. PubMed ID: 17476542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.